How Gut Bacteria Train Regulatory T Cells to Keep Inflammation in Check
This review maps how gut microbes and their polysaccharides and metabolites shape regulatory T cells, and how dysbiosis may drive IBD and autoimmunity.
Summary
Regulatory T cells (Tregs) are the immune system's peacekeepers, and the gut microbiota helps decide how many develop and how well they work. This review describes how bacterial and fungal molecules, including Bacteroides fragilis polysaccharide A, Bifidobacterium cell-surface polysaccharides, and yeast mannan/β-glucans, signal through receptors such as TLR2 and Dectin-1 on dendritic cells to induce Tregs. It also covers newly described RORγt+ antigen-presenting cells (ILC3s and Thetis cells) that generate microbiota-specific Tregs around weaning. Dysbiosis, with fewer protective microbes and lower SCFA and bile acid signals, is linked to inflammatory bowel disease and autoimmunity. The authors highlight the therapeutic promise of probiotics, microbial ligands, and live biotherapeutics, while noting that most evidence comes from mice and that effects depend on context.
Detailed Summary
Why it matters: The gut hosts trillions of microbes that the immune system must tolerate while still fighting pathogens. CD4+Foxp3+ regulatory T cells (Tregs) are central to this balance. When microbe-Treg communication breaks down, chronic inflammation and autoimmune disease, including inflammatory bowel disease (IBD), can follow. Understanding the signals involved could open new ways to restore tolerance.
What was reviewed: This is a narrative review (not a new experiment) by Sharma, Sharma and Im. It synthesizes work on how the microbiota shapes thymic and peripheral Tregs, which microbial structural components and metabolites drive Treg differentiation, and how dysbiosis undermines tolerance. The portion of the full text available covers thymic Treg development, antigen-induced peripheral Tregs, and three classes of microbial ligands; the sections on metabolites such as SCFAs, tryptophan derivatives and bile acids are introduced but not detailed in the available text.
Key results: Germ-free mice have underdeveloped immune systems and smaller thymuses, and antibiotic depletion worsens intestinal inflammation. Microbial influence on thymic Tregs is suggested by overlapping TCR repertoires between thymic and colonic Tregs, but the mechanism remains unclear. Peripheral RORγt+ Tregs, which mediate tolerance to commensals, arise in a window around weaning. Recent studies point to RORγt+ antigen-presenting cells rather than conventional CD103+ dendritic cells: Lyu et al. implicated ILC3s acting via integrin αvβ3, whereas Akagbosu et al. identified Thetis cells (using integrin αvβ8 and TGF-β) and found ILC3s dispensable, a discrepancy possibly due to different Cre drivers. Human data show Thetis-like cells enriched in fetal mesenteric lymph nodes. Microbial ligands include B. fragilis polysaccharide A (PSA, a TLR2 ligand that induces Tregs and suppresses Th17, with fewer PSA-producing strains seen in IBD biopsies), Bifidobacterium bifidum PRI1 cell-surface β-glucan/galactan polysaccharides (CSGG, which act on TLR2 in dendritic cells to induce IL-10 and TGF-β and protect against colitis), and yeast-derived mannan/β-1,6-glucan polysaccharides (MGCP, acting via Dectin-1 and TLR2 with Cox2). B. bifidum PRI1 also generated a PD-1−CXCR3+ colonic Treg subset with stronger suppressive capacity.
Implications: These ligands could underpin next-generation probiotics, prebiotics and live biotherapeutic products for IBD and other immune-mediated disease. HLA genotype may also shape microbiota-Treg interactions, pointing toward personalized approaches.
Caveats: Effects are strongly context-dependent. The same TLR2 pathway can expand Tregs or push them toward a Th17-like state, and microbes such as SFB, Prevotella copri, AIEC and Helicobacter hepaticus can promote inflammation in susceptible hosts. Much of the evidence comes from mouse models, and human validation is limited.
Key Findings
- Peripheral RORγt+ Tregs mediate tolerance to gut microbes and are generated during a critical early-life window around weaning.
- RORγt+ antigen-presenting cells (ILC3s or Thetis cells), not conventional CD103+ DCs, appear key to inducing microbiota-specific Tregs via integrin-activated TGF-β.
- Microbial polysaccharides (B. fragilis PSA, Bifidobacterium CSGG, yeast MGCP) induce Tregs through TLR2/Dectin-1 on dendritic cells and protect against colitis in mice.
- Bifidobacterium bifidum PRI1 drove a PD-1−CXCR3+ colonic Treg subset with greater suppressive capacity and IL-10 production.
- Dysbiosis, including fewer PSA-producing B. fragilis, is linked to IBD, while pathobionts and SFB can promote inflammation by suppressing Tregs or favoring Th17.
Methodology
This is a narrative review synthesizing mostly preclinical mouse studies (germ-free, monocolonization, conditional knockouts, single-cell RNA sequencing), supplemented by limited human tissue and biopsy data and the authors' own prior work. No systematic search or quantitative pooling is described.
Study Limitations
Most mechanistic evidence comes from mouse models and may not translate to humans, and key questions such as the thymic origin of microbiota-induced Tregs and the role of Thetis cells in humans remain unresolved. Conflicting results between studies, and context-dependent TLR2 effects, complicate therapeutic prediction. The review is narrative and authored partly by groups promoting their own strains, and the full text provided was truncated before the metabolite sections.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: